An Association of Racing Commissioners International (RCI) committee will meet July 26 to hear opinions and testimony on use of race-day medication in racehorses.

The Drug Testing Standards and Practices Committee will meet in Saratoga Springs, N.Y., the RCI said in a July 18 release. It is designed to offer regulators a chance to ask questions they couldn’t broach during an international race-day drug summit in June.

"Although the summit was helpful, there was limited opportunity for regulators to ask questions of the participants," RCI president Ed Martin said in a statement. "It was the consensus of those present that a follow-up meeting was necessary. The central question for regulators is the extent to which the removal of this medication on those days a horse actually races would pose any significant equine health risk."

The committee will hear from Tom David, DVM, chairman of the RCI Regulatory Veterinarian Committee; Scott Palmer, VMD, who chairs the American Association of Equine Practitioners Racing Committee; N. Edward Robinson, BVetMed, PhD, from the Center for Integrative Toxicology at the Veterinary Medical Center at Michigan State University; and others